How should stress-dose glucocorticoid therapy be initiated and tapered in a critically ill patient with suspected adrenal insufficiency?

Critical Illness Corticosteroid Deficiency: Stress-Dose Glucocorticoid Initiation and Tapering

In critically ill patients with suspected adrenal insufficiency, initiate hydrocortisone 100 mg IV bolus immediately, followed by continuous infusion of 200-240 mg/24 hours (or 50 mg IV every 6 hours), and taper only after hemodynamic stability is achieved for at least 7 days. 1, 2

Immediate Initiation Protocol

When to Suspect and Treat

Suspect critical illness-related corticosteroid insufficiency (CIRCI) in any critically ill patient with:

• Hypotension poorly responsive to fluids and vasopressors
• Septic shock requiring vasopressor support
• Hyponatremia and/or hyperkalemia without clear cause
• Signs of hemodynamic instability with vomiting or diarrhea 1, 3

Do not delay treatment while awaiting diagnostic testing. If the patient has current or recent glucocorticoid use and presents with hemodynamic instability, treat immediately as adrenal crisis 4.

Initial Dosing Strategy

For moderate to major stress or hemodynamic instability:

• Give hydrocortisone 100 mg IV bolus immediately
• Follow with continuous IV infusion of 200-240 mg/24 hours (10 mg/hour), OR
• Administer hydrocortisone 50 mg IV every 6 hours 5, 1, 2

The continuous infusion is superior to bolus dosing because it maintains cortisol concentrations persistently in the range observed during major stress, whereas intermittent boluses create peaks and troughs that fail to sustain adequate levels 2. Linear pharmacokinetic modeling confirms that continuous infusion of 200 mg over 24 hours, preceded by a 50-100 mg bolus, best maintains required cortisol concentrations 2.

For minor stress without hemodynamic instability:

• Oral glucocorticoids may be used if no vomiting/diarrhea present
• Double the usual oral dose for 24-48 hours 4, 5

Concurrent Management

• Aggressive fluid resuscitation with 0.9% sodium chloride (10-20 mL/kg bolus, repeat as needed)
• Continue vasopressor support as required
• Monitor blood glucose hourly (treat if <3.5 mmol/L)
• Check sodium and potassium levels
• Do not use fludrocortisone acutely - high-dose hydrocortisone provides sufficient mineralocorticoid activity 4, 5

Diagnostic Considerations

Testing Approach

The ACTH stimulation test should NOT be used to determine who receives glucocorticoids in septic shock - treat based on clinical presentation 1. However, if testing is performed:

• Random total cortisol <10 μg/dL indicates adrenal insufficiency
• Delta cortisol <9 μg/dL after ACTH (250 μg) suggests inadequate response
• In hypoproteinemic patients, random total cortisol ≥9.5 μg/dL is expected; free cortisol ≥1.8 μg/dL is more reliable 1, 6

If you must perform ACTH testing and cannot delay treatment: Use dexamethasone 4 mg IV instead of hydrocortisone initially, as it does not interfere with cortisol assays 3. However, dexamethasone is NOT recommended for ongoing CIRCI treatment 1.

Tapering Protocol

Duration of High-Dose Therapy

Continue stress-dose hydrocortisone for minimum 7 days in septic shock 1, 7. For severe ARDS (PaO₂/FiO₂ <200 within 14 days of onset), methylprednisolone 1 mg/kg/day should continue for ≥14 days 1.

Tapering Strategy

Do not stop glucocorticoids abruptly - this risks precipitating adrenal crisis 1.

Step-down approach:

1. After hemodynamic stability achieved (typically 7+ days):

   • Reduce to hydrocortisone 50 mg IV every 12 hours for 2-3 days
   • Then 50 mg IV daily for 2-3 days

2. Transition to oral therapy:

   • Switch to oral hydrocortisone 30-50 mg/day in divided doses (typically 20 mg morning, 10 mg afternoon)
   • Continue for several days to weeks depending on clinical course 5

3. Further taper to physiologic dosing:

   • Reduce gradually to physiologic replacement (15-25 mg hydrocortisone daily)
   • This represents the equivalent of normal daily cortisol production 4

4. Assessment of HPA axis recovery:

   • Once on physiologic dosing, check morning cortisol (8 AM, before dose)
   • If >300 nmol/L (10 μg/dL): discontinue glucocorticoids
   • If 150-300 nmol/L (5-10 μg/dL): continue physiologic dose, recheck in weeks to months
   • If <150 nmol/L (5 μg/dL): continue physiologic dose, recheck in few months 4

Critical Pitfall: Recurrence of Symptoms

If signs of sepsis, hypotension, or worsening oxygenation recur during taper, immediately reinstitute stress-dose therapy 1. This is a common error - clinicians taper too aggressively and miss early signs of inadequate cortisol coverage.

Special Populations

Patients with Prior Glucocorticoid Exposure

Any patient with current or recent glucocorticoid use (within past year) who presents critically ill should be assumed to have glucocorticoid-induced adrenal insufficiency until proven otherwise 4. This includes:

• Inhaled/topical glucocorticoids >1 year
• Intra-articular injections within 2 months
• Any supraphysiologic oral dose >3-4 weeks
• Patients with cushingoid features 4

Surgical Patients

For surgery under general/regional anesthesia:

• Hydrocortisone 100 mg IV at induction
• Continuous infusion 200 mg/24 hours while NPO
• Resume oral dosing at double dose for 24-48 hours post-op 5

Key Contraindications and Cautions

The commonly used "low-dose" hydrocortisone 50 mg every 6 hours (200 mg/day) actually produces serum cortisol levels severalfold higher than physiologic 6. While this is appropriate for acute stress, recognize this is supraphysiologic and requires tapering.

Avoid high-dose "pulse" steroids (methylprednisolone ≥30 mg/kg/day) - these provide no benefit in septic shock and may cause harm 3.

Patients without HPA axis recovery after 1 year on physiologic dosing require endocrinology referral 4.